Get comprehensive EEF1A2 Gene Mental Retardation Autosomal Dominant Type 38 NGS Genetic DNA Testing for $500 USD in USA. Advanced neurological disorder diagnosis available in New York
Get the ATRX Gene Mental Retardation with Hypotonic Facies Syndrome X-Linked NGS Genetic DNA Test for only $500 USD in USA. Comprehensive next-generation sequencing testing for neurological disorders available in New York ATRX Gene Mental Retardation with Hypotonic Facies Syndrome X-Linked Genetic Test Original price was: $700.Current price is: $500.
Get comprehensive CRBN Gene Mental Retardation Autosomal Recessive Type 2 NGS Genetic DNA Test for $500 USD in USA. Advanced next-generation sequencing technology detects mutations causing intellectual disability and neurological conditions. Available in major cities including New York CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test Original price was: $700.Current price is: $500.
Sale!

EEF1A2 Gene Mental Retardation Autosomal Dominant Type 38 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The EEF1A2 Gene Mental Retardation Autosomal Dominant Type 38 NGS Genetic DNA Test is a specialized diagnostic examination that identifies mutations in the EEF1A2 gene, which is associated with autosomal dominant intellectual disability. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variations responsible for neurological developmental disorders. Individuals experiencing unexplained intellectual disability, developmental delays, or neurological symptoms should consider this test for accurate diagnosis. The test provides crucial information for treatment planning and genetic counseling, helping families understand inheritance patterns. Results are typically available within 3-4 weeks from sample collection. This advanced genetic testing is available for $500 USD, offering significant savings from the regular $700 USD price. Our testing facilities are conveniently located across major US cities.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

EEF1A2 Gene Mental Retardation Autosomal Dominant Type 38 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Development Disorders

The EEF1A2 Gene Mental Retardation Autosomal Dominant Type 38 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying specific genetic mutations associated with intellectual disability and neurological developmental disorders. This specialized test focuses on the EEF1A2 gene, which plays a critical role in protein synthesis and neuronal function. Mutations in this gene have been directly linked to autosomal dominant mental retardation type 38, making accurate genetic testing essential for proper diagnosis and management.

What Does This Test Measure and Detect?

This advanced genetic test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the EEF1A2 gene for pathogenic variants. The test specifically detects:

  • Point mutations and single nucleotide variants in the EEF1A2 gene
  • Small insertions and deletions affecting gene function
  • Missense mutations that alter protein structure and function
  • Pathogenic variants associated with autosomal dominant inheritance patterns
  • Genetic markers linked to neurological development impairment

Who Should Consider This Genetic Test?

This specialized genetic testing is recommended for individuals presenting with:

  • Unexplained intellectual disability or developmental delays
  • Family history of autosomal dominant neurological disorders
  • Early-onset cognitive impairment without clear etiology
  • Suspected genetic basis for learning disabilities
  • Neurological symptoms consistent with EEF1A2-related disorders
  • Children with developmental milestones significantly behind peers
  • Individuals with affected family members showing similar neurological patterns

Clinical Benefits of EEF1A2 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Provides definitive identification of EEF1A2 gene mutations
  • Personalized Treatment Planning: Enables targeted therapeutic interventions
  • Genetic Counseling: Supports informed family planning decisions
  • Early Intervention: Facilitates timely educational and therapeutic support
  • Prognostic Information: Helps predict disease progression and outcomes
  • Family Risk Assessment: Identifies at-risk relatives for preventive measures

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your EEF1A2 test results:

  • Positive Result: Indicates the presence of a pathogenic EEF1A2 mutation, confirming the diagnosis of autosomal dominant mental retardation type 38
  • Negative Result: Suggests no detectable EEF1A2 mutation, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring further evaluation
  • Carrier Status: Determines inheritance patterns and family risk assessment

All results are accompanied by detailed genetic counseling to ensure complete understanding and appropriate next steps.

Test Pricing and Availability

Test Feature Details
Test Name EEF1A2 Gene Mental Retardation Autosomal Dominant Type 38 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Pre-Test Requirements and Preparation

Before undergoing testing, we recommend:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications with healthcare providers
  • Understanding of potential outcomes and their significance

Take Control of Your Neurological Health Today

Don’t let uncertainty about neurological development concerns affect your quality of life. Our EEF1A2 genetic testing provides the clarity needed for informed healthcare decisions and personalized treatment approaches. With our discounted pricing at $500 USD and comprehensive genetic counseling support, you can access world-class neurological genetic testing without financial burden.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic specialists about your testing needs.

Early genetic diagnosis can significantly impact treatment outcomes and quality of life. Take the first step toward understanding your neurological health with our advanced EEF1A2 genetic testing services.

SKU: 2967 Category:

Related products